Substance

SPARTALIZUMAB

Global reference: every product and company linked to this substance.

ANTI-PD1 MONOCLONAL ANTIBODY PDR001 · NVP-LZV184 · PDR-001 · PDR001 · spartalizumab [INN] · SPARTALIZUMAB [JAN] · SPARTALIZUMAB [USAN] · Spartalizumab [WHO-DD]

Revenue by product (0)

No revenue reported for this substance in loaded filings.

A figure belongs to the product it was reported for. It is never summed across companies or across a company's products, so one substance in three products shows three figures.

Products containing this substance (0)

    Companies holding this asset (1)